Economy

Trump picks former intel director John Ratcliffe to head the CIA

John Ratcliffe, who served as President-elect Trump’s principal intelligence advisor during his first presidential term, will serve as the director of the Central Intelligence Agency when Trump moves back into the White House.  

Ratcliffe is one of several appointees announced in the past week who will fill key positions during Trump’s second term. 

‘From exposing fake Russian collusion to be a Clinton campaign operation, to catching the FBI’s abuse of Civil Liberties at the FISA Court, John Ratcliffe has always been a warrior for Truth and Honesty with the American Public,’ Trump said in a statement. ‘When 51 intelligence officials were lying about Hunter Biden’s laptop, there was one, John Ratcliffe, telling the truth to the American People.’

Trump honored Ratcliffe in 2020 with the National Security Medal, the highest honor for distinguished achievement in the field of intelligence and national security.

Ratcliffe previously served under Trump as Director of National Intelligence (DNI). 

‘In that role, Ratcliffe served as the leader of the U.S. intelligence community and principal intelligence advisor to President Trump. Before that role, Ratcliffe served in Congress for over five years as the U.S. representative for the 4th Congressional District of Texas.

This post appeared first on FOX NEWS

You May Also Like

Investing

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

Latest News

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

Investing

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

Investing

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 GreatWallStreetPublisher.com

Exit mobile version